2021. Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s38. DOI:https://doi.org/10.25251/skin.5.supp.38.